Fesoterodin-Mepha 4 mg, Retardtabletten - 14 Swissmedic Key 68790001 Registration Holder Mepha Pharma AG Name Fesoterodin-Mepha 4 mg, Retardtabletten Date of registration 27.06.2022 Original/Generic Generic Introduction of Sequence 27.06.2022 ATC-Classification Fesoterodine (G04BD11) Revision date WHO WHO-DDD Valid until 26.06.2027 Index Therapeuticus (BSV) 05.02. Show package size 14 Index Therapeuticus (Swissmedic) 05.02. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 9.02 Limitation No Deductible 10 % Consumer price 26.25 Feedback FB Daily cost GTIN 7680687900010 Medication Code Synthetika Pharmacode Disponibility
Composition fesoterodini fumaras 4.0 mg corresp. fesoterodinum 3.1 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 127.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, glyceroli monocaprylocapras, natrii laurilsulfas, E 132, pro compresso obducto, natrium 0.045 mg. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Fesoterodini Fumaras 4 mg correspond Fesoterodinum 3.1 mg
BAG: Active Agent Dose Fesoterodini Fumaras 4 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum E 132 color. E 171 color. Glyceroli Dibehenas Glyceroli Monocaprylocapras Hypromellosum Lactose Monohydrate 127.125 mg Natrii Laurilsulfas Sodium 0.045 mg Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
